To further understand the mechanism contributing to decreased monocyte-induced NK cell activation, we next determined the levels of CD16 surface expression on CD14+ monocytes of healthy individuals and those of the cancer patients using flow cytometry. This evidence concerns the gene CD14 and cancer.